COMPASS DIVERSIFIED SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Compass Diversified Holdings – CODI

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 8, 2025 to file lead plaintiff applications in a securities class action lawsuit against Compass Diversified Holdings (NYSE: CODI), if they purchased the Company's securities between May 1, 2024 and […]

OGN INVESTOR NOTICE: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

The law firm of Robbins Geller Rudman & Dowd LLP announces that the Organon class action lawsuit – captioned Hauser v. Organon & Co., No. 25-cv-05322 (D.N.J.) – seeks to represent purchasers or acquirers of Organon & Co. (NYSE: OGN) securities and charges Organon and certain of Organon's top executives with violations of the Securities

A NEW ERA IN COLLEGE SPORTS BEGINS: COURT APPROVES LANDMARK HOUSE SETTLEMENT, NEW COLLEGE SPORTS COMMISSION LAUNCHES

Today marks a historic milestone for college athletics in the United States. The U.S. District Court for the Northern District of California has granted final approval to a settlement in the House v. NCAA (“House”) litigation. This landmark settlement – agreed to by plaintiffs representing nearly 400,000 current and former student-athletes and the NCAA, Atlantic

MediPharm Labs’ Board Continues Value Destruction for Shareholders with Sale of Hope Facility

Complete Incompetence at the Board Level Results in Fire Sale of Treasured MediPharm Asset, the Hope Facility, to a Competitor Hope Facility was One of Canada's Best Cultivation Assets Before it was Acquired by MediPharm, Grossly Mismanaged, and Ultimately Shut Down in 2024 MediPharm Labs' Board is Pursuing its Worst Deal Yet: A Highly Dilutive

MediPharm Labs’ Board Continues Value Destruction for Shareholders with Sale of Hope Facility

MediPharm Labs' Board Continues Value Destruction for Shareholders with Sale of Hope Facility GlobeNewswire June 07, 2025 Complete Incompetence at the Board Level Results in Fire Sale of Treasured MediPharm Asset, the Hope Facility, to a Competitor Hope Facility was One of Canada's Best Cultivation Assets Before it was Acquired by MediPharm, Grossly Mismanaged, and

Aura Announces Public Filing of Registration Statement for Proposed U.S. Public Offering

(TSX:ORA),(Bovespa:AURA33.SA),(OTC US:ORAAF),(Other OTC:ORAAF),(Bovespa:AURA33), ROAD TOWN, British Virgin Islands, June 06, 2025 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) (“Aura” or the “Company”) announces that it has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed public offering of

Aura Announces Public Filing of Registration Statement for Proposed U.S. Public Offering

Aura Announces Public Filing of Registration Statement for Proposed U.S. Public Offering GlobeNewswire June 07, 2025 ROAD TOWN, British Virgin Islands, June 06, 2025 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) (“Aura” or the “Company”) announces that it has publicly filed a registration statement on Form F-1 with the U.S.

ProZenith Launches Natural Supplement Formulated for Weight Management Support

Aurora, June 06, 2025 (GLOBE NEWSWIRE) — ProZenith recently announced the launch of its new wellness supplement developed to assist individuals in maintaining energy, focus, and mindful appetite awareness as part of a balanced and active lifestyle. Manufactured in the United States in a facility that is FDA-registered and GMP-certified, the product is now available

ProZenith Launches Natural Supplement Formulated for Weight Management Support

ProZenith Launches Natural Supplement Formulated for Weight Management Support U.S.-Made Product Supports General Wellness Goals with a 60-Day Refund Policy GlobeNewswire June 07, 2025 Aurora, June 06, 2025 (GLOBE NEWSWIRE) — ProZenith recently announced the launch of its new wellness supplement developed to assist individuals in maintaining energy, focus, and mindful appetite awareness as part

URGN INVESTOR DEADLINE: UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, inclusive (the “Class Period”), have until July 28, 2025 to seek appointment as lead plaintiff of the UroGen class action lawsuit. Captioned Cockrell v. UroGen

Scroll to Top